A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

NCT03417427 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid

Interventions

DRUG: Decitabine and Ara-C
DRUG: Ara-C

Sponsor

Xuejie Jiang